Immunometabolism is an emerging field that impacts immunological studies cutting across many fields like infectious diseases, cancer, autoimmune diseases etc. Our research group studies how our body’s metabolic pathways shape immune responses during infections. We investigate how mitochondrial metabolism like respiration, lipid and amino acid catabolism regulate specific leukocyte functions. This approach provides critical insight into why immune responses are often dysregulated in patients with metabolic diseases such as diabetes, who face poorer outcomes during infections. 

To drive these discoveries, we leverage cutting-edge technologies including single-cell RNA sequencing (scRNA-seq), advanced metabolomics, metabolic quantification platforms, and high-throughput flow cytometry.  Through this multidisciplinary strategy, we aim to uncover novel metabolic pathways that govern immune activation and pave the way for innovative therapies to improve patient health.